scispace - formally typeset
J

Josef Jampilek

Researcher at Comenius University in Bratislava

Publications -  331
Citations -  6091

Josef Jampilek is an academic researcher from Comenius University in Bratislava. The author has contributed to research in topics: Lipophilicity & Chemistry. The author has an hindex of 36, co-authored 303 publications receiving 4695 citations. Previous affiliations of Josef Jampilek include Palacký University, Olomouc & Slovak Academy of Sciences.

Papers
More filters
Journal ArticleDOI

Trimethoxycinnamates and Their Cholinesterase Inhibitory Activity

TL;DR: In this paper, a series of 12 nature-inspired 3,4,5-trimethoxycinnamates were tested for their ability to inhibit AChE and butyrylcholinesterase (BChE) in vitro; the selectivity index was also determined.
Patent

Alaptide : methods of effecting its solubility, membrane permeation and pharmaceutical compositions for human and/or veterinary applications

TL;DR: In this paper, the authors deal with the way of effecting the solubility of alaptide by the addition of low- molecular or high-molecular compounds or by generation of nanoparticles.
Journal ArticleDOI

Synthesis and photosynthetic electron transport inhibition of 2-substituted 6-fluorobenzothiazoles

TL;DR: A series of 10 N-substituted 2-(aminoethyl)-6-fluorobenzothiazoles inhibited photosynthetic electron transport in spinach chloroplasts as mentioned in this paper.
Journal ArticleDOI

Silver Nanoparticles Stabilized with Phosphorus-Containing Heterocyclic Surfactants: Synthesis, Physico-Chemical Properties, and Biological Activity Determination.

TL;DR: In this article, a comparison with non-heterocyclic alkyltrimethylphosphonium surfactants showed better stability and more positive zeta potential values for silver nanodispersions stabilized with a series of ammonium and phosphonium bromides.
Journal ArticleDOI

Electrochemistry of ring-substituted 1-hydroxynaphthalene-2-carboxanilides: Relation to structure and biological activity

TL;DR: In vitro screening against Mycobacterium tuberculosis was performed here for the first time with 1-hydroxy-N-(3-trifluoromethylphenyl)naphthalene-2-carboxamide being the most effective and several other compounds showed higher antimycobacterial activity than the standard isoniazid.